Analysis of 11 consecutive patients who developed intracranial hemorrhage during warfarin therapy with PT-INR less than 2.0 and antidoted with administration of 4-factor prothrombin complex concentrate-Reference-Cited by-同舟云学术

Analysis of 11 consecutive patients who developed intracranial hemorrhage during warfarin therapy with PT-INR less than 2.0 and antidoted with administration of 4-factor prothrombin complex concentrate

Published:2024 Issue:1 Volume:37 Page:13-16
ISSN:0917-074X
Container-title:Neurosonology
language:en
Short-container-title:Neurosonalogy

Author:

ABE Daisuke¹²,YASAKA Masahiro¹³,KUWASHIRO Takahiro¹,MURAYA Yohei¹,MIZOGUCHI Tadataka¹,TAGAWA Naoki¹,MORI Kota¹,SUGIMORI Hiroshi¹,OKADA Yasushi¹

Affiliation:

1. Department of Cerebrovascular Medicine and Neurology, National Hospital Organization Kyushu Medical Center

2. Department of Cerebrovascular Medicine, Kyushu Rosai Hospital

3. Department of Cerebrovascular Medicine, Fukuoka Neurosurgical Hospital

Publisher

Japan Academy of Neurosonology

Link

https://www.jstage.jst.go.jp/article/neurosonology/37/1/37_13/_pdf

Reference6 articles.

1. 1) Steiner T, Poli S, Griebe M, et al.: Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial. Lancet Neurol 2016; 15: 566-573.

2. 2) Rivosecchi RM, Durkin J, Okonkwo DO, et al.: Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage. Neurocrit Care 2016; 25: 359-364.

3. 3) Zemrak WR, Smith KE, Rolfe SS, et al.: Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. Neurocrit Care 2017; 27: 334-340.

4. 4) ケイセントラ^®添付文書2021年3月改訂（第1版）

5. 5) ケイセントラ^®使用成績調査最終報告2020年6月